Genetic testing is a cornerstone of precision medicine. By identifying specific mutations and biomarkers, genetic tests can help determine the most effective therapies. For instance, the presence of the BRCA1 or BRCA2 mutation in breast cancer patients can indicate a higher likelihood of response to PARP inhibitors.
